Bayer shares registered yet another sharp decrease on Thursday (16 August), dropping as much as 6.5% in Frankfurt to hover near the 76 euros level as investors fear the German chemicals and pharmaceuticals giant may face numerous litigations in the US after its controversial merger with Monsanto.
Pharmaceutical companies face a multi-million euro bill in regulatory costs regardless of whether the UK reaches a ‘soft’ or ‘hard’ Brexit deal with the European Union, industry leaders warned on Tuesday (19 December).
Organisations of patients with rare diseases have warned EU policymakers to “think carefully” before reviewing the incentives in the orphan drugs regulation, claiming that the pharma industry should not be discouraged from investing in new therapies.
EXCLUSIVE / An EU infringement procedure launched against Hungary about a law that regulates pharmacies has been unjustifiably stalled for more than two years, raising concerns among foreign investors.
The European Commission has remained silent over a cruel but perfectly legal practice, common in South America, of rearing pregnant horses for their blood in order to harvest a hormone that is used in veterinary products imported to Europe. EURACTIV Germany reports.
EXCLUSIVE / National healthcare systems should embrace the digital era and use Health Technology Assessment (HTA) to become truly sustainable and cost-effective, European Commissioner for Health and Food Safety Vytenis Andriukaitis told EURACTIV.com in an interview.
Unused pharmaceuticals, which end up in the environment, such as in groundwater, pose a major threat to public health and the environment, by leading to the development of antimicrobial resistance (AMR) in humans.
Europe's pharmaceuticals industry said on Tuesday (1 September) it had filed a complaint with the European Commission against a French law promoting the use of Roche's cancer drug Avastin as an alternative to more expensive eye treatments.
Modern pharmaceuticals are no longer exclusively produced in a chemicals laboratory, but are often developed using live cells. In Germany, such biopharmaceuticals are being sold and prescribed at an ever increasing rate – despite widespread scepticism over GMOs in Germany. EURACTIV Germany reports.
A recent European comparison shows Germany’s expenditures on pharmaceuticals are above average. No other country offers medications for treating illnesses “as quickly and comprehensively” as the Federal Republic. EURACTIV Germany reports.
Paracetamol tablets are the world’s most commonly used painkillers. According to a recent study published in the British journal Annals of the Rheumatic Diseases, prolonged use of the drug can have very harmful side effects. EURACTIV France reports.
Pharmaceutical drugs, and medical technology, will remain under the department of health (DG Sanco) in the next Commission, Jean-Claude Juncker, the President-elect, confirmed on Wednesday (22 October).
Jean-Claude Juncker has ceded to pressure from MEPs and abandoned his plan to return control of medicines and pharmaceutical products to the Industry Commissioner. This responsibility will instead remain in the hands of the Health Commissioner, EURACTIV France reports.
Europe’s pharmaceutical industry has said it did not lobby for medicines and medical devices to be moved from the European Commission's health directorate (DG Sanco) to the enterprise directorate (DG Enterprise).
The German government initiated plans on Monday (15 September) to strengthen the country’s attractiveness for pharmaceutical research and development, but the Left Party warns it is likely to become an "image campaign" for pharmaceutical giants. EURACTIV.de reports.
A new EU regulation is meant to make clinical trials easier and more transparent, a pivotal tool in the fight against deadly diseases like cancer. But researchers in Germany warn that the country may lose its role as a leader in international medicine. EURACTIV Germany reports.
José Antonio Bastos, head of doctors without borders (MSF) in Spain, has spoken out against big pharmaceutical companies that "only think in terms of profit" and pay little attention to "real health needs" of the population in developing countries,EURACTIV Spain reports.
The pharmaceutical industry is trying to 'mobilise' patient groups into lobbying against EU plans that will force companies to publish data from their clinical trials, according to an e-mail seen by a British newspaper.